News & Events

We have put together an overview of industry partnership programs for translational life science research in academia (and start-ups). The document features calls from Daiichi-Sankyo, CSL, Debiopharm and others, covering deadlines, topic areas, collaboration formats, and application guidance. Beyond funding (CHF 40k to several hundred thousand), these programs in many cases offer direct access to industry expertise, infrastructure, materials, and networks.

Download the document HERE and see what's in it for you!

_____________________________________________

Another SPARK night focusing on MedTech topics took place on May 27th. Two outstanding teams presented their projects to a panel of industry advisors and Medtech experts:

- Skaaltec presented by Paulius Viskaitis, developing a non-invasive approach for vagus nerve stimulation to support the rehabilitation of stroke patients

- MutaDent presented by Isaac Maximiliano Bugueno Valdebenito and Argyro Lamprou, Ph.D, developing a regenerative biomaterial for deep carious lesions with the potential to actively restore damaged dental tissue and reduce the need for root canal treatments and tooth extraction

_____________________________________________

The Swiss Biotech Day is coming up next week on the 4.5. and 5.5. in Basel and we are very glad to announce that Anna Hanzl and Mirco Müller from our team will participate! Looking forward to exciting meetings and presentations all around the Biotech Space.
In case you are thinking about how to build a LifeScience StartUp, want to learn how you can get involved in our translational expert community or just exchange on current trends please reach out to us.

_____________________________________________

We are thrilled to officially welcome Anna Hanzl to the TMA! Anna brings a PhD in molecular biology and recent experience consulting for the Boston Consulting Group. She will lead the TMA's initiatives in industry relations among other things. We are looking forward to working with her!

_____________________________________________

Another exciting SPARK Night here at the TMA: We had three outstanding teams who presented their approaches and challenges to a panel of industry advisors and drug development experts

- Marc H. from CypherCure: Developing a novel algorithm to identify highly immunogenic antigens for cancer vaccines

- Massimo Saini from Apheryon: Working on a novel liquid biopsy technology to extract large numbers of circulating tumour cells to support the development of personalized cancer therapies

- Nicolò Pernigoni Pernigoni from MicThera (visiting from USI Università della Svizzera italiana): Developing a novel therapeutic approach to treat late-stage metastatic prostate cancer

_____________________________________________

We had the chance to hear from three outstanding projects who presented their approach and challenges to a panel of Medtech industry experts:

- Patrick Weber and Hao Liu Lui from Lumios: Developing novel 3D-printed nerve grafts

- Cornel Dillinger and Pedro Pereira Amado from SonoStent: Working on a surface coating for urethral stents that can be cleaned from biofilm using ultrasound

- Kevin Yim from EVIIVE: Pioneering a new blood test to select the optimal immunotherapy treatment for melanoma patients

_____________________________________________

At this week’s SPARK Night, we had the chance to hear from three outstanding founders who presented their projects and challenges to a panel of industry experts and investors:

- Vincent Forster from Nerai Bioscience AG: Pioneering gene therapies based on a precision gene-editing platform

- Gregor Bordon, PhD from Eldian Biomed: Developing a novel approach to treat osteoarthritis

- Antonis Katsoulas from Innunity Therapeutics: Working on new therapies for neurodegenerative diseases

_____________________________________________

_____________________________________________

_____________________________________________

_____________________________________________

_____________________________________________

_____________________________________________

_____________________________________________

_____________________________________________

_____________________________________________

_____________________________________________

_____________________________________________

_____________________________________________